Trial
NCT00591149
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Kansas Medical Center
Collaborators
Sanofi
Condition
Head and Neck Cancer
Intervention
Oxaliplatin
Why stopped
Study was stopped due to termination of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-14